Blog

Conducting Clinical Trials

Part 2Author: Dr. Cheryl L. Rowe-Rendleman In the United States, “biological products” are subject to a different premarket pathway and differing intellectual property protections than products regulated as “drugs”.... read more

Obtaining Early Regulatory Advice — INTERACT Meetings

Part 1Author: Dr. Cheryl L. Rowe-Rendleman In the United States, “biologic products” are subject to a different premarket pathway than products regulated as “drugs”. This 3-part blog series describes... read more

IN MEMORY OF A YW WOMAN ON A MISSION

Amanda DeAngelis (née Sileo) joined the YWCA Princeton in 2017 as a Communications and Marketing Manager, and was an inaugural member of the NEXT GEN Board. She was a... read more